Benchmarking the Confidence of Large Language Models in Answering Clinical Questions: Cross-Sectional Evaluation...

The capabilities of large language models (LLMs) to self-assess their own confidence in answering questions within the biomedical realm remain underexplored.

This study evaluates the confidence levels of 12 LLMs across 5 medical specialties to assess LLMs' ability to accurately judge their own responses.

We used 1965 multiple-choice questions that assessed clinical knowledge in the following areas: internal medicine, obstetrics and gynecology, psychiatry, pediatrics, and general surgery. Models were prompted to provide answers and to also provide their confidence for the correct answers (score: range 0%-100%). We calculated the correlation between each model's mean confidence score for correct answers and the overall accuracy of each model across all questions. The confidence scores for correct and incorrect answers were also analyzed to determine the mean difference in confidence, using 2-sample, 2-tailed t tests.

The correlation between the mean confidence scores for correct answers and model accuracy was inverse and statistically significant (r=-0.40; P=.001), indicating that worse-performing models exhibited paradoxically higher confidence. For instance, a top-performing model-GPT-4o-had a mean accuracy of 74% (SD 9.4%), with a mean confidence of 63% (SD 8.3%), whereas a low-performing model-Qwen2-7B-showed a mean accuracy of 46% (SD 10.5%) but a mean confidence of 76% (SD 11.7%). The mean difference in confidence between correct and incorrect responses was low for all models, ranging from 0.6% to 5.4%, with GPT-4o having the highest mean difference (5.4%, SD 2.3%; P=.003).

Better-performing LLMs show more aligned overall confidence levels. However, even the most accurate models still show minimal variation in confidence between right and wrong answers. This may limit their safe use in clinical settings. Addressing overconfidence could involve refining calibration methods, performing domain-specific fine-tuning, and involving human oversight when decisions carry high risks. Further research is needed to improve these strategies before broader clinical adoption of LLMs.